Global Sirolimus-eluting Stents Market size is expected to reach USD 11.81 Bn. by year 2030 at a CAGR of 5.5% during the forecast period.Global Sirolimus-eluting Stents Market Overview:
Drug-eluting implants Stents are expandable tubes made of wire that is implanted into the coronary arteries of patients with atherosclerosis to keep the artery open by releasing a drug that prevents the artery from being blocked again and enhances blood flow. Sirolimus is a macrolide drug used to coat coronary stents, prevent organ transplant rejection, and treat rare lung disease.To know about the Research Methodology :- Request Free Sample Report
Global Sirolimus-eluting Stents Market Dynamics:
Increasing cases of cardiovascular diseases is the major factor driving the market growth.
The rising prevalence of cardiovascular diseases and the growing demand for minimally invasive surgeries are the primary factors boosting the market growth. The use of a minimally invasive surgical technique, which is the main growth factor, has resulted in a decline in post-operative trauma and complications. Other benefits of using advanced and miniaturized coronary stents include shorter hospital stays and faster recovery times. The demand for sirolimus-eluting stents is largely driven by the growing geriatric population, which is at a higher risk of developing arterial disorders. Furthermore, unhealthy eating patterns, sedentary lifestyles, and a lack of exercise raise the prevalence of atherosclerosis globally, propelling the market growth. Advantages associated with Sirolimus stents such as, it is lipid-soluble also known as lipophilic due to which almost no drug is released into the bloodstream during stent implantation at the lesion site, it also favours the diffusion gradient elution into tissue after stent implantation, aids the market growth of Sirolimus-eluting stents. In addition to its antibiotic properties, Sirolimus was discovered to have potent anti-proliferative and anti-inflammatory properties. This factor also adds up to the market growth. Other factors such as increasing novel product launches and FDA approvals, technological advancements and rising investments in research & development propel the market growth. However, the market growth is being hampered by the declining prices of these devices. Furthermore, drug-eluting stents carry the risk of stent thrombosis and endothelial tissue destruction during regrowth. In the forecast period, these factors are expected to pose a threat to the market's development. The report has profiled eighteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.Global Sirolimus-eluting Stents Market Segment Analysis:
The Global Sirolimus-eluting Stents Market is segmented on the basis of Type, Application and End-Users.
Based on the Type, polymer free segment holds the dominant market share. Polymer-free coating stents are made up of Microporous stents and inorganic coatings that can be drug-loaded. Several drugs have been used in the development of carrier-free stents, including tacrolimus, paclitaxel, sirolimus, and probucol. Furthermore, the polymer-free coating has benefits such as eliminating inflammatory problems caused by polymers used in stents and allowing anti-proliferative drugs to be released directly from the stent surface. The growing geriatric population, rising prevalence of cardiovascular diseases, and the demand for minimally invasive procedures are driving the polymer-free coating stents market. Based on the Application, coronary artery disease segment is expected to dominate the global market during the forecast period. The coronary artery disease segment is expected to grow at a CAGR of 9.3% during forecast years. The American Heart Association states that Coronary artery disease is the leading cause of death in the US, affecting more than 13 million people. In the US, almost 610,000 people die of heart disease per year, accounting for one out of every four deaths. Due to a rise in the prevalence of coronary artery disease, increased use of drug-eluting stents and rising device approvals in the treatment of coronary artery disease boosts the segment growth.Global Sirolimus-eluting Stents Market Regional Insights:
North America holds the dominant market share.
The North America region is expected to continue the dominance throughout the forecast period. The regional growth is accounted to the growing prevalence of cardiovascular diseases and the government’s support for reimbursement policies. Furthermore, technological advances in drug-eluting stents, as well as the existence of well-established healthcare infrastructure, are both contributing to the overall regional market's growth.APAC is expected to witness lucrative growth during forecast period.
During the forecast period, India, China, Brazil, and South Africa would have the highest growth rates. Growing awareness of commercial availability of drugs, government financing, constantly developing healthcare facilities, and that healthcare spending are all factors contributing to the market's substantial growth in these countries. The report also helps in understanding Global Sirolimus-eluting Stents Market dynamics, structure by analyzing the market segments and project the Global Sirolimus-eluting Stents Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Sirolimus-eluting Stents Market make the report investor’s guide.Global Sirolimus-eluting Stents Market Scope: Inquire before buying
Sirolimus-eluting Stents Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 8.12 Bn. Forecast Period 2024 to 2030 CAGR: 5.5% Market Size in 2030: USD 11.81 Bn. Segments Covered: by Type Polymer based Polymer free by Application Coronary Artery Disease Peripheral Artery Disease by End-Users Hospitals Ambulatory surgical centers Others Global Sirolimus-eluting Stents Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Global Sirolimus-eluting Stents Market, Key players:
1. STENTYS SA 2. iVascular SLU 3. nano Therapeutics Pvt. Ltd 4. S3V Vascular Technologies 5. Meril Life Sciences Pvt. Ltd. 6. Micell Technologies, Inc. 7. B. Braun Melsungen AG 8. SMT 9. Eurocor Tech GmbH 10. Boston Scientific Corporation 11. Medtronic, Inc. 12. Abbott Laboratories 13. Biosensors International Group 14. Biotronik 15. Lepu Medical Technology 16. Terumo Medical Corporation 17. Cook Medical 18. Shandong JW Medical SystemsFrequently Asked Questions:
1. Which region has the largest share in Global Sirolimus-eluting Stents Market? Ans: North America region held the highest share in 2023. 2. What is the growth rate of Global Sirolimus-eluting Stents Market? Ans: The Global Sirolimus-eluting Stents Market is growing at a CAGR of 5.5% during forecasting period 2024-2030. 3. What is scope of the Global Sirolimus-eluting Stents Market report? Ans: Global Sirolimus-eluting Stents Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Sirolimus-eluting Stents Market? Ans: The important key players in the Global Sirolimus-eluting Stents Market are – STENTYS SA, iVascular SLU, nano Therapeutics Pvt. Ltd, S3V Vascular Technologies, Meril Life Sciences Pvt. Ltd., Micell Technologies, Inc., B. Braun Melsungen AG, SMT, Eurocor Tech GmbH, Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, and Shandong JW Medical Systems. 5. What is the study period of this Market? Ans: The Global Sirolimus-eluting Stents Market is studied from 2023 to 2030.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Sirolimus-eluting Stents Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2023 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Sirolimus-eluting Stents Market 3.4. Geographical Snapshot of the Sirolimus-eluting Stents Market, By Manufacturer share 4. Global Sirolimus-eluting Stents Market Overview, 2023-2030 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Sirolimus-eluting Stents Market 5. Supply Side and Demand Side Indicators 6. Global Sirolimus-eluting Stents Market Analysis and Forecast, 2023-2030 6.1. Global Sirolimus-eluting Stents Market Size & Y-o-Y Growth Analysis. 7. Global Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 7.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 7.1.1. Polymer based 7.1.2. Polymer free 7.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 7.2.1. Coronary Artery Disease 7.2.2. Peripheral Artery Disease 7.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 7.3.1. Hospitals 7.3.2. Ambulatory surgical centers 7.3.3. Others 8. Global Sirolimus-eluting Stents Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2023-2030 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 9.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 9.1.1. Polymer based 9.1.2. Polymer free 9.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 9.2.1. Coronary Artery Disease 9.2.2. Peripheral Artery Disease 9.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 9.3.1. Hospitals 9.3.2. Ambulatory surgical centers 9.3.3. Others 10. North America Sirolimus-eluting Stents Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 11.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 11.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 11.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 12. Canada Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 12.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 12.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 12.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 13. Mexico Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 13.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 13.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 13.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 14. Europe Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 14.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 14.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 14.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 15. Europe Sirolimus-eluting Stents Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 16.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 16.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 16.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 17. France Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 17.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 17.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 17.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 18. Germany Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 18.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 18.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 18.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 19. Italy Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 19.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 19.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 19.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 20. Spain Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 20.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 20.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 20.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 21. Sweden Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 21.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 21.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 21.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 22. CIS Countries Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 22.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 22.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 22.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 23. Rest of Europe Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 23.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 23.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 23.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 24. Asia Pacific Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 24.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 24.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 24.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 25. Asia Pacific Sirolimus-eluting Stents Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 26.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 26.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 26.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 27. India Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 27.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 27.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 27.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 28. Japan Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 28.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 28.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 28.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 29. South Korea Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 29.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 29.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 29.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 30. Australia Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 30.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 30.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 30.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 31. ASEAN Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 31.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 31.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 31.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 32. Rest of Asia Pacific Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 32.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 32.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 32.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 33. Middle East Africa Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 33.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 33.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 33.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 34. Middle East Africa Sirolimus-eluting Stents Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 35.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 35.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 35.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 36. GCC Countries Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 36.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 36.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 36.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 37. Egypt Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 37.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 37.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 37.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 38. Nigeria Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 38.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 38.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 38.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 39. Rest of ME&A Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 39.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 39.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 39.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 40. South America Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 40.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 40.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 40.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 41. South America Sirolimus-eluting Stents Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 42.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 42.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 42.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 43. Argentina Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 43.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 43.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 43.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 44. Rest of South America Sirolimus-eluting Stents Market Analysis and Forecasts, 2023-2030 44.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 44.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 44.3. Market Size (Value) Estimates & Forecast By End-Users, 2023-2030 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Sirolimus-eluting Stents Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. STENTYS SA 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. iVascular SLU 45.3.3. nano Therapeutics Pvt. Ltd 45.3.4. S3V Vascular Technologies 45.3.5. Meril Life Sciences Pvt. Ltd. 45.3.6. Micell Technologies, Inc. 45.3.7. B. Braun Melsungen AG 45.3.8. SMT 45.3.9. Eurocor Tech GmbH 45.3.10. Boston Scientific Corporation 45.3.11. Medtronic, Inc. 45.3.12. Abbott Laboratories 45.3.13. Biosensors International Group 45.3.14. Biotronik 45.3.15. Lepu Medical Technology 45.3.16. Terumo Medical Corporation 45.3.17. Cook Medical 45.3.18. Shandong JW Medical Systems 46. Primary Key Insights
